Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women

International Journal of Cardiology

Volumn 261, Issue , 2018, Pages 189-195

  Glisic, Marija ^a   Rojas, Lyda Z ^a   Asllanaj, Eralda ^a   Vargas, Kris G ^a   Kavousi, Maryam ^a   Ikram, M Arfan ^a   Fauser, Bart C J M ^b   Laven, Joop S E ^a   Muka, Taulant ^a   Franco, Oscar H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endogenous sex hormones; Menopause; Natriuretic peptides; NT pro BNP; Postmenopausal women

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANDROSTENEDIONE; ESTRADIOL; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; ANDROGEN; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); SEX HORMONE;

AGE; AGED; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; LIFESTYLE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REPRODUCTION; TESTOSTERONE BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; NETHERLANDS;

AGED; ANDROGENS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; PEPTIDE FRAGMENTS; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN;

EID: 85043790065     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2018.03.008     Document Type: Article

References (38)

1. Witteman, J.C., Grobbee, D.E., Kok, F.J., Hofman, A., Valkenburg, H.A., Increased risk of atherosclerosis in women after the menopause. BMJ 298:6674 (1989), 642–644.
2. Clerico, A., Giannoni, A., Vittorini, S., Emdin, M., The paradox of low BNP levels in obesity. Heart Fail. Rev. 17:1 (2012), 81–96.
3. Kavousi, M., Elias-Smale, S., Rutten, J.H., Leening, M.J., Vliegenthart, R., Verwoert, G.C., et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann. Intern. Med. 156:6 (2012), 438–444.
4. Rutten, J.H., Mattace-Raso, F.U., Steyerberg, E.W., Lindemans, J., Hofman, A., Wieberdink, R.G., et al. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension 55:3 (2010), 785–791.
5. Pfister, R., Sharp, S., Luben, R., Welsh, P., Barroso, I., Salomaa, V., et al. Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med., 8(10), 2011, e1001112.
6. Chang, A.Y., Abdullah, S.M., Jain, T., Stanek, H.G., Das, S.R., McGuire, D.K., et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J. Am. Coll. Cardiol. 49:1 (2007), 109–116.
7. Grimes, D.A., Lobo, R.A., Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstet. Gynecol. 100:6 (2002), 1344–1353.
8. Daan, N.M., Muka, T., Koster, M.P., Roeters van Lennep, J.E., Lambalk, C.B., Laven, J.S., et al. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J. Clin. Endocrinol. Metab. 101:9 (2016), 3306–3315.
9. Lam, C.S., Cheng, S., Choong, K., Larson, M.G., Murabito, J.M., Newton-Cheh, C., et al. Influence of sex and hormone status on circulating natriuretic peptides. J. Am. Coll. Cardiol. 58:6 (2011), 618–626.
10. Ober, C., Loisel, D.A., Gilad, Y., Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 9:12 (2008), 911–922.
11. Jankowski, M., Rachelska, G., Donghao, W., McCann, S.M., Gutkowska, J., Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc. Natl. Acad. Sci. U. S. A. 98:20 (2001), 11765–11770.
12. Nakamura, S.Y.M., Nakayama, M., Ito, T., Mizuno, Y., Harada, E., Sakamoto, T., Saito, Y., Nakao, K., Yasue, H., Ogawa, H., Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart. Circulation 110:13 (2004), 1787–1793.
13. Rexrode, K.M., Manson, J.E., Lee, I.M., Ridker, P.M., Sluss, P.M., Cook, N.R., et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 108:14 (2003), 1688–1693.
14. Sutton-Tyrrell, K., Wildman, R.P., Matthews, K.A., Chae, C., Lasley, B.L., Brockwell, S., et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the study of women across the nation (SWAN). Circulation 111:10 (2005), 1242–1249.
15. Hofman, A., Brusselle, G.G., Darwish Murad, S., van Duijn, C.M., Franco, O.H., Goedegebure, A., et al. The Rotterdam study: 2016 objectives and design update. Eur. J. Epidemiol. 30:8 (2015), 661–708.
16. R., B.D., Multiple Imputation for Nonresponse in Surveys. (Investigative radiology), 1987.
17. Januzzi, J.L., van Kimmenade, R., Lainchbury, J., Bayes-Genis, A., Ordonez-Llanos, J., Santalo-Bel, M., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study. Eur. Heart J. 27:3 (2006), 330–337.
18. Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed). 2016, 69(12), 2016, 1167.
19. Lin, E., McCabe, E., Newton-Cheh, C., Bloch, K., Buys, E., Wang, T., et al. Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot study. Fertil. Steril. 97:2 (2012), 489–493.
20. Parker, L.N., Odell, W.D., Control of adrenal androgen secretion. Endocr. Rev. 1:4 (1980), 392–410.
21. Orentreich, N., Brind, J.L., Rizer, R.L., Vogelman, J.H., Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59:3 (1984), 551–555.
22. Altman, R., Motton, D.D., Kota, R.S., Rutledge, J.C., Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vasc. Pharmacol. 48:2–3 (2008), 76–84.
23. Barrett-Connor, E., Khaw, K.T., Yen, S.S., A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N. Engl. J. Med. 315:24 (1986), 1519–1524.
24. Catalano, M.G., Frairia, R., Boccuzzi, G., Fortunati, N., Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells. Mol. Cell. Endocrinol. 230:1–2 (2005), 31–37.
25. Fortunati, N., Catalano, M.G., Boccuzzi, G., Frairia, R., Sex hormone-binding globulin (SHBG), estradiol and breast cancer. Mol. Cell. Endocrinol. 316:1 (2010), 86–92.
26. Liu, D., Dillon, J.S., Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J. Biol. Chem. 277:24 (2002), 21379–21388.
27. Rosner, W.H.D., Khan, M.S., Nakhla, A.M., Romas, N.A., Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem. Mol. Biol. 69:1–6 (1999), 481–485.
28. Santhanakrishnan, R., Lam, C.S., Natriuretic peptides, gender and cardiovascular risk: what is the link?. Maturitas 71:2 (2012), 89–91.
29. Maffei, S., Del Ry, S., Prontera, C., Clerico, A., Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clin. Sci. (Lond.) 101:5 (2001), 447–453.
30. Noubani, A., Farookhi, R., Gutkowska, J., B-type natriuretic peptide receptor expression and activity are hormonally regulated in rat ovarian cells. Endocrinology 141:2 (2000), 551–559.
31. Rosner, W., Auchus, R.J., Azziz, R., Sluss, P.M., Raff, H., Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab. 92:2 (2007), 405–413.
32. Vermeulen, A., Verdonck, L., Kaufman, J.M., A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84:10 (1999), 3666–3672.
33. Pizzi, C., De Stavola, B., Merletti, F., Bellocco, R., dos Santos Silva, I., Pearce, N., et al. Sample selection and validity of exposure-disease association estimates in cohort studies. J. Epidemiol. Community Health 65:5 (2011), 407–411.
34. Yeo, K.T., Wu, A.H., Apple, F.S., Kroll, M.H., Christenson, R.H., Lewandrowski, K.B., et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the biosite triage BNP assay. Clin. Chim. Acta 338:1–2 (2003), 107–115.
35. Perrone, R.D., Madias, N.E., Levey, A.S., Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. 38:10 (1992), 1933–1953.
36. Caspersen, C.J., Bloemberg, B.P., Saris, W.H., Merritt, R.K., Kromhout, D., The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen study, 1985. Am. J. Epidemiol. 133:11 (1991), 1078–1092.
37. Stel, V.S., Smit, J.H., Pluijm, S.M., Visser, M., Deeg, D.J., Lips, P., Comparison of the LASA physical activity questionnaire with a 7-day diary and pedometer. J. Clin. Epidemiol. 57:3 (2004), 252–258.
38. Fukuyama, N., Homma, K., Wakana, N., Kudo, K., Suyama, A., Ohazama, H., et al. Validation of the Friedewald equation for evaluation of plasma LDL-cholesterol. J. Clin. Biochem. Nutr. 43:1 (2008), 1–5.